就药物涂层支架的最新进展做一综述。
The development of drug-eluting stents is reviewed in this paper.
本文综述了药物涂层支架相关问题的研究进展。
In this paper the research progress of interrelated issues about the drug-coated stent is reviewed.
药物涂层支架的应用显著降低了支架内再狭窄的发生。
In-stent restenosis has been significantly reduced by utilization of drug eluting stents.
结论药物涂层支架置入可显著降低冠脉介入术后再狭窄率。
Conclusion Drug-eluting stent implantation can decrease the rate of restenosis significantly in coronary intervention.
现在大部分医生都建议这种接受药物涂层支架植入的患者不定期的服用抗凝药物。
Those who get drug-coated stents are now told by most doctors to take anti-clotting drugs indefinitely.
从1998年到2005年，诸如心脏除颤器，药物涂层支架这样的设备普及的越来越快。
From 1998 to 2005 the use of equipment such as defibrillators and drug-eluting stents expanded rapidly.
目的：从材料学及临床应用方面阐述如何提高老年心血管疾病中药物涂层支架的相容性。
OBJECTIVE: To investigate how to elevate the compatibility of drug-eluting stent in elderly cardiovascular disease from aspects of material and clinical application.
目的：了解抗增殖作用药物涂层支架的种类和特点及其在临床应用中的有效性和亟待解决的问题。
OBJECTIVE: To understand the types and characteristics of anti-proliferative drug-eluting stent, and its effectiveness in clinical applications and problems to be solved.
美敦力公司的药物涂层支架有望在12月底获得批准，华尔街预测Xience有望在明年夏天投放市场。
Medtronic is expected to gain approval for its drug-coated Endeavor stent as early as the end of December, and Wall Street anticipates that Xience could reach the market by the summer.
几乎所有接受支架植入的病人用的都是较老的金属裸支架，因为药物涂层支架直到2003年才进入美国市场。
Nearly all of the patients stented received the older bare metal versions, because drug-coated stents did not enter the American market until 2003.
现对药物涂层支架内血栓形成的相关临床证据和病理生理机制，特别是药物涂层支架本身在其中的作用进行综述。
This article reviews the clinical evidence and pathophysiological mechanisms of stent thrombosis of drug-eluting stent, especially the role of the stent itself in it.
但是当新证据显示，药物涂层支架将导致几个月或几年之内的血栓形成的危险度增加的时候，这种应用开始减少了。
But use has fallen since new evidence emerged that drug-coated stents carry a slightly higher risk of triggering blood clots months or years later.
近年来研究发现，它在抗移植排斥反应、作为药物涂层支架用于冠脉狭窄、抗肿瘤等方面均有作用，临床应用范围广。
It has been used widely in clinic because of its many effects especially in inhibiting graft rejective reaction, coating frame used in coronary stenosis and anti-tumor from recent study.
随着对冠状动脉介入治疗后再狭窄机理研究的进展和涂层支架技术的研发成功，使药物涂层支架预防再狭窄成为可能。
With the progress of studying restenosis mechanism after coronary interventions therapy and successness of coated stent technology, it is possible to prevent from the restenosis by coated stents.
药物涂层支架市场在去年减少了，而某种程度上正因为这项新心脏病研究，这个市场在今年被预言将以更快的速度减少。
The drug-coated stent market shrank last year and is expected to erode at a faster rate this year, due in part to anticipation of the newest heart study.
药物涂层支架的销售自上一个春天以来就开始下降了，因为研究发现一小部分病人在植入这类支架后会有可能致命的血栓形成。
Sales of the drug-coated stents have been falling since last spring because studies showed that potentially deadly clots form in a small percentage of patients long after they are implanted.
一些研究表明这两种支架相关的死亡率和心脏病发生率都非常接近，但是美敦力和艾博特公司的更新的药物涂层支架也许会改变这个结果。
Some studies suggest that death and heart attack rates are similar for the two types of stent, but newer drug-coated products from companies like Medtronic and Abbott Laboratories may change that.
从2003年开始，这个市场就是由药物涂层支架占主导地位，因为在阻止出现新的阻塞方面，药物涂层支架要比纯金属支架的效果更好。
Since 2003, the market has been dominated by drug-coated devices because they do a better job of preventing new clogging than the bare-metal stents that preceded them.
分析人士估计如果Xience能够顺利上市，它将在未来几年里获得药物涂层支架市场45%的份额，美国药物涂层支架市场每年的总量大概是18亿美元。
The analysts estimate that Xience could gain as much as 45 percent of a $1.8 billion American annual market for drug-coated stents over the next few years.
该涂层在保证与金属支架间良好结合的同时，能够实现负载药物的缓慢释放，有效避免爆释现象。
The coating can realize slow release of loaded medicine while ensuring better bonding with a metal stent, and effectively avoids burst release.
本发明提供的是一种左旋多巴(L - DOPA)改性有机-无机复合药物缓释支架涂层的制备方法。
The invention relates to a preparation method of an L-DOPA (levodopa) modified organic-inorganic composite medicine slow release stent coating.
在基线水平两组之间血管造影结果相似。支架在两个月的时间内有完全相同的生物学可降解的多聚物涂层和洗脱药物。
Both groups had similar angiographic characteristics at baseline. The stents had an identical biodegradable polymeric coating and eluted drugs over a 2-month period.
在基线水平两组之间血管造影结果相似。支架在两个月的时间内有完全相同的生物学可降解的多聚物涂层和洗脱药物。
Both groups had similar angiographic characteristics at baseline. The stents had an identical biodegradable polymeric coating and eluted drugs over a 2-month period.
应用推荐